lactic acid has been researched along with cardiovascular agents in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.70) | 18.7374 |
| 1990's | 1 (2.17) | 18.2507 |
| 2000's | 12 (26.09) | 29.6817 |
| 2010's | 29 (63.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, K; Hiroki, T; Kumagai, S; Moriyama, Y; Mutaguchi, T; Shindo, M; Tanaka, H; Yoshida, T | 1 |
| Asaka, N; Kirimoto, T; Miyake, H; Muranaka, Y | 1 |
| Avazov, N; Diver, A; Klein, R; Oxman, T; Rabinowitz, B; Shapira, M | 1 |
| Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K | 1 |
| Alm, A; Mäepea, O; Narfström, K; Nilsson, SF | 1 |
| Biondi, C; Dalpiaz, A; Forni, F; Pavan, B; Scatturin, A; Vandelli, MA | 1 |
| Chang, L; Du, JB; Gao, LR; Pang, YZ; Tang, CS | 1 |
| KLUPP, H; KOBINGER, W; KRAUPP, O | 1 |
| CARR, CJ; COSMIDES, GJ; MIYA, TS | 1 |
| ANFOSSI, F; ANSELMINO, A; BERT, G; BIANCO, A; MIGHELI, B; PUPITA, F | 1 |
| Chevalier, B; de Bruyne, B; Dudek, D; Ormiston, JA; Serruys, PW; Tanimoto, S; Thuesen, L | 1 |
| Lemos, PA | 1 |
| Abraham, NG; Baldi, S; Barsacchi, R; Drummond, GS; L'Abbate, A; Masiello, P; McClung, JA; Neglia, D; Novelli, M; Ottaviano, V; Paolicchi, A; Vecoli, C | 1 |
| Fernández, MA; González, M; Perazzo, JC; Prendes, MG; Savino, EA; Torresín, E; Varela, A | 1 |
| Egashira, K; Endo, Y; Funakoshi, K; Hara, K; Kawashima, Y; Kimura, S; Masuda, S; Matoba, T; Nakano, K; Sueishi, K; Sunagawa, K; Tominaga, R; Tsujimoto, H; Zhao, G | 1 |
| Agostoni, P; Birkemeyer, R; Grube, E; Haine, S; Haude, M; Jung, W; Müller, R; Sarno, G; van Langenhove, G; Verheye, S; Vrints, C; Wijns, W; Willems, T | 1 |
| Ormiston, JA; Serruys, PW | 1 |
| Bruining, N; Cheong, WF; de Winter, S; Dudek, D; Hamers, R; Heller, I; Miquel-Hebert, K; Onuma, Y; Ormiston, JA; Regar, E; Roelandt, JR; Serruys, PW; Thuesen, L; van Domburg, RT; Veldhof, S; Webster, MW | 1 |
| Antoniucci, D; Bernardi, V; Bettinoti, M; Curotto, V; Delacasa, A; Fernandez-Pereira, C; Mieres, J; Palacios, IF; Rodriguez, AE; Rodriguez-Granillo, AM; Rodriguez-Granillo, G; Rubilar, B; Santaera, O; Tronge, J; Vigo, CF | 1 |
| Ma, H; Wang, S; Yang, H; Zhang, X; Zhu, Y; Zou, J | 1 |
| Chiang Boey, FY; Huang, CL; Kumar, S; Loo, JS; Steele, TW; Venkatraman, SS; Widjaja, E | 1 |
| Hong, D; Li, H; Liu, J; Tan, L; Xia, Y; Xu, K; Yang, K; Zhang, B; Zheng, F; Zhong, H | 1 |
| Fujii, K; Hayashi, Y; Ikari, Y; Inoue, N; Iwabuchi, M; Kadota, K; Kimura, T; Mitsudo, K; Muramatsu, T; Namiki, A; Nanto, S; Saito, S | 1 |
| Brugaletta, S; Chevalier, B; de Bruyne, B; Dudek, D; Gijsen, F; Gutiérrez-Chico, JL; McClean, DR; Onuma, Y; Ormiston, J; Regar, E; Serruys, PW; Thuesen, L; Wentzel, J; Whitbourn, R; Windecker, S | 1 |
| Bayer, G; Diener, T; Joner, M; Koppara, T; Steigerwald, K; Wittchow, E | 1 |
| Attizzani, G; Balvedi, JA; Centeno, PR; Kosachenco, BG; Matte, BS; Nascimento, L; Raudales, JC; Yamamoto, GI; Zago, AC; Zago, AJ | 1 |
| Carvalho, AC; De Luca, FA; Gun, C; Medeiros, WM; Peres, P | 1 |
| Hagiwara, H; Hirai, T; Hiraishi, Y; Inoue, K; Kimura, J; Murota, S; Sakaoka, A; Sasaki, M; Terao, H | 1 |
| Arlt, M; Camboni, D; Hilker, M; Keyser, A; Lubnow, M; Lunz, D; Philipp, A; Rupprecht, L; Schmid, C; Schopka, S; Zacher, R; Zimmermann, M | 1 |
| Daimon, T; Fukushima, S; Kawaguchi, N; Matsuura, N; Miyagawa, S; Nakatani, S; Okita, Y; Saito, A; Sakai, Y; Sawa, Y; Shiozaki, M; Shirasaka, T | 1 |
| Berzina-Cimdina, L; Loca, D; Makrecka, M; Sevostjanovs, E; Sokolova, M; Tupureina, V; Zharkova-Malkova, O | 1 |
| Abizaid, A; Abizaid, AS; Bhat, V; Chamie, D; Costa, JR; Costa, R; Morrison, L; Ormiston, JA; Pinto, I; Sanidas, E; Stewart, J; Toyloy, S; Verheye, S; Webster, M; Yan, J | 1 |
| De Backer, D; Vincent, JL | 1 |
| Deng, W; Ge, J; Toft, E; Wang, S; Wang, X; Zhang, H | 1 |
| Carrio, ML; Esteve, F; Farrero, E; Javierre, C; Lopez-Delgado, JC; Manez, R; Rodríguez-Castro, D; Torrado, H; Ventura, JL | 1 |
| Kim, CS; Lee, CW; Lee, S | 1 |
| McCrossan, BA; McMahon, CJ; Walsh, KP | 1 |
| Campos, CM; Cho, YK; Dijkstra, J; Eggermont, J; Garcia-Garcia, HM; Ishibashi, Y; Kamberi, M; Lane, J; Nakatani, S; Onuma, Y; Perkins, L; Rapoza, R; Reiber, JH; Serruys, PW; Sheehy, A | 1 |
| Deng, Y; Liu, Y; Zha, D; Zhang, Q; Zhang, W | 1 |
| Blanco-Prieto, MJ; Garbayo, E; Pascual-Gil, S; Prosper, F; Simón-Yarza, T | 1 |
| Coviello, V; Dario, P; Filippeschi, C; La Motta, C; Menciassi, A; Piazza, V; Pingue, P; Ricotti, L; Sartini, S; Vannozzi, L | 1 |
| Egashira, K; Katsuki, S; Koga, J; Matoba, T; Nakano, K; Nakashiro, S; Sunagawa, K; Tokutome, M; Umezu, R | 1 |
| Chatterjee, A; Chen, M; Conte, MS; Desai, TA; Lance, KD; Mottola, G; Siguenza, IO; Wu, B | 1 |
| Hästbacka, J; Hjortrup, PB; Jakob, SM; Karlsson, S; Kuitunen, A; Lange, T; Merz, T; Perner, A; Pettilä, V; Takala, J; Wilkman, E | 1 |
| Arana, C; Dager, A; Delgado, JA; Gasior, P; Généreux, P; Granada, JF; Hernandez, H; Higuera, S; Maehara, A; Moncada, M; Vesga, B | 1 |
| Gao, R; Guan, C; Guo, Y; Li, Y; Li, Z; Qiao, S; Qin, L; Song, L; Sun, Z; Xu, B | 1 |
2 review(s) available for lactic acid and cardiovascular agents
| Article | Year |
|---|---|
Bioabsorbable coronary stents.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Humans; Lactic Acid; Magnesium; Polycarboxylate Cement; Polyesters; Polymers; Prosthesis Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Circulatory shock.
Topics: Cardiotonic Agents; Cardiovascular Agents; Diagnosis, Differential; Fluid Therapy; Humans; Lactic Acid; Shock; Vasoconstrictor Agents; Vasodilator Agents | 2013 |
8 trial(s) available for lactic acid and cardiovascular agents
| Article | Year |
|---|---|
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic).
Topics: Aged; Angioplasty, Balloon, Coronary; Belgium; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Germany; Humans; Lactic Acid; Male; Middle Aged; Myocardial Infarction; Polyesters; Polymers; Prospective Studies; Prosthesis Design; Severity of Illness Index; Tacrolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Europe; Everolimus; Feasibility Studies; Humans; Image Interpretation, Computer-Assisted; Lactic Acid; New Zealand; Polyesters; Polymers; Predictive Value of Tests; Prosthesis Design; Sirolimus; Solubility; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Argentina; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Glycocalyx; Humans; Kaplan-Meier Estimate; Lactic Acid; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Japan; Lactic Acid; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Polyesters; Polymers; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome | 2012 |
The dysfunction of ammonia in heart failure increases with an increase in the intensity of resistance exercise, even with the use of appropriate drug therapy.
Topics: Adult; Ammonia; Biomarkers; Brazil; Cardiovascular Agents; Cross-Over Studies; Heart Failure; Humans; Hyperammonemia; Hyperkalemia; Lactic Acid; Male; Middle Aged; Muscle, Skeletal; Potassium; Purines; Resistance Training; Time Factors; Treatment Outcome | 2014 |
A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Topics: Absorbable Implants; Aged; Aged, 80 and over; Belgium; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Lactic Acid; Male; Materials Testing; Models, Cardiovascular; Multidetector Computed Tomography; Multimodal Imaging; Myocardial Infarction; Neointima; New Zealand; Percutaneous Coronary Intervention; Polyesters; Polymers; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Time Factors; Tissue Scaffolds; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency | 2014 |
Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
Topics: Arterial Pressure; Biomarkers; Cardiotonic Agents; Cardiovascular Agents; Clinical Protocols; Combined Modality Therapy; Data Interpretation, Statistical; Europe; Feasibility Studies; Fluid Therapy; Hemodynamics; Humans; Lactic Acid; Microcirculation; Models, Statistical; Prospective Studies; Regional Blood Flow; Renal Replacement Therapy; Research Design; Respiration, Artificial; Sample Size; Shock, Septic; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
Topics: Absorbable Implants; Adsorption; Aged; Cardiovascular Agents; China; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Kinetics; Lactic Acid; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prospective Studies; Prosthesis Design; Recurrence; Risk Factors; Sirolimus; Treatment Outcome | 2017 |
36 other study(ies) available for lactic acid and cardiovascular agents
| Article | Year |
|---|---|
Effect of nifedipine, dilazep, dinitrates and propranolol on blood lactate accumulation during intensive graded exercise testing in healthy young subjects.
Topics: Adult; Blood Pressure; Cardiovascular Agents; Dilazep; Exercise Test; Heart Rate; Humans; Lactates; Lactic Acid; Nifedipine; Nitrates; Propranolol | 1988 |
Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts.
Topics: Administration, Oral; Animals; Cardiovascular Agents; Carnitine; Coronary Circulation; Glucose; Glycolysis; Heart; Hypoglycemic Agents; Hypoxia; In Vitro Techniques; Insulin; Lactic Acid; Male; Methylhydrazines; Myocardial Contraction; Oxidation-Reduction; Palmitates; Phosphates; Rats; Rats, Sprague-Dawley | 1998 |
A new method of long-term preventive cardioprotection using Lactobacillus.
Topics: Adenosine Triphosphate; Animals; Body Temperature; Cardiovascular Agents; Catalase; Coronary Circulation; Epoprostenol; Hemodynamics; HSP70 Heat-Shock Proteins; Lactic Acid; Lactobacillus; Male; Myocardial Ischemia; Norepinephrine; Pharmaceutical Preparations; Rats; Rats, Sprague-Dawley; Recovery of Function; Reperfusion Injury; Tachycardia | 2000 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate | 2000 |
Ocular blood flow and retinal metabolism in abyssinian cats with hereditary retinal degeneration.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Cardiovascular Agents; Cats; Choroid; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Heart Rate; Indomethacin; Lactic Acid; Male; Nitroarginine; Regional Blood Flow; Retina; Retinal Degeneration; Retinal Vessels | 2001 |
Poly(lactic acid) microspheres for the sustained release of antiischemic agents.
Topics: Adenosine; Animals; Cardiovascular Agents; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Delayed-Action Preparations; Drug Compounding; Humans; In Vitro Techniques; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Polyesters; Polymers; Receptors, Purinergic P1 | 2002 |
Effect of ghrelin on septic shock in rats.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Cardiovascular Agents; Ghrelin; Hemodynamics; Lactic Acid; Male; Myocardium; Peptide Hormones; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Rate | 2003 |
[Changes of potassium and lactic acid level in the blood following administration of neuromusculardepressant substances].
Topics: Blood; Cardiovascular Agents; Humans; Lactic Acid; Muscle Relaxants, Central; Potassium | 1954 |
A study of the effects of certain lactones on digitoxin toxicity.
Topics: Cardiovascular Agents; Digitalis; Digitoxin; Drug-Related Side Effects and Adverse Reactions; Lactic Acid; Lactones | 1956 |
[Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
Topics: Biphenyl Compounds; Cardiovascular Agents; Coronary Disease; Humans; Lactates; Lactic Acid; Prenylamine; Propylamines | 1963 |
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Biocompatible Materials; Biomechanical Phenomena; Cardiovascular Agents; Chromium Alloys; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Lactic Acid; Male; Middle Aged; Polyesters; Polymers; Prosthesis Design; Research Design; Sirolimus; Tomography, Optical Coherence | 2007 |
Polymeric stents: degradable but strong.
Topics: Angioplasty, Balloon, Coronary; Biocompatible Materials; Biomechanical Phenomena; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Lactic Acid; Polyesters; Polymers; Prosthesis Design; Sirolimus | 2007 |
Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats.
Topics: Adiponectin; Animals; bcl-X Protein; Cardiovascular Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Induction; Heme Oxygenase (Decyclizing); Lactic Acid; Male; Malondialdehyde; Microcirculation; Myocardial Reperfusion Injury; Myocardium; Niacinamide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Protoporphyrins; Rats; Rats, Wistar; Severity of Illness Index; Streptozocin; Superoxides; Time Factors; Up-Regulation; Vascular Resistance; Vasoconstriction | 2007 |
Protection of ischaemic-reperfused rat heart by dimethylamiloride is associated with inhibition of mitochondrial permeability transition.
Topics: Amiloride; Animals; Cardiovascular Agents; Cell Survival; Cyclosporine; Female; Glycolysis; In Vitro Techniques; Lactic Acid; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; Perfusion; Permeability; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2008 |
Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Cations; Cells, Cultured; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Feasibility Studies; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Kinetics; Lactic Acid; Male; Materials Testing; Models, Animal; Muscle, Smooth, Vascular; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Design; Stainless Steel; Sus scrofa | 2009 |
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Topics: Animals; Blotting, Western; Cardiovascular Agents; Carotid Arteries; Carrier Proteins; Cell Proliferation; Cells, Cultured; Delayed-Action Preparations; Drug Carriers; Endothelial Cells; Graft Survival; Hyperplasia; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Jugular Veins; Lactic Acid; Light; Male; Microscopy, Electron, Transmission; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nanoparticles; Phosphoproteins; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Scattering, Radiation; Sirolimus; Solubility; Tunica Intima; Vascular Grafting | 2011 |
High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.
Topics: Cardiovascular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Coumarins; Delayed-Action Preparations; Drug Carriers; Fluoresceins; Fluorescent Dyes; High-Throughput Screening Assays; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy; Microscopy, Electron, Scanning; Molecular Structure; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Solubility; Spectrometry, Fluorescence; Spectrum Analysis, Raman; Surface Properties; Technology, Pharmaceutical; Thiazoles | 2011 |
Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention of restenosis.
Topics: Alloys; Angioplasty; Animals; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Dioxanes; Disease Models, Animal; Drug-Eluting Stents; Endothelial Cells; Hyperplasia; Lactic Acid; Magnesium; Male; Polyesters; Polymers; Prosthesis Design; Rabbits; Secondary Prevention; Sirolimus; Time Factors; Wound Healing | 2011 |
Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Australia; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Vessels; Europe; Everolimus; Female; Humans; Lactic Acid; Male; Middle Aged; Neointima; New Zealand; Polyesters; Polymers; Predictive Value of Tests; Prosthesis Design; Registries; Sirolimus; Time Factors; Tissue Scaffolds; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Lactic Acid; Models, Animal; Neointima; Polyesters; Polyglactin 910; Polymers; Prosthesis Design; Sirolimus; Sus scrofa; Time Factors; Tissue Distribution | 2012 |
Local delivery of sirolimus nanoparticles for the treatment of in-stent restenosis.
Topics: Acrylic Resins; Animals; Cardiac Catheters; Cardiovascular Agents; Chemistry, Pharmaceutical; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Equipment Design; Infusions, Parenteral; Lactic Acid; Nanoparticles; Neointima; Percutaneous Coronary Intervention; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Sirolimus; Swine; Time Factors; Ultrasonography, Interventional | 2013 |
Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Granuloma; Inflammation; Lactic Acid; Lymphocytes; Metals; Microscopy, Electron, Scanning; Models, Animal; Polyesters; Polymers; Prosthesis Design; Sirolimus; Swine; Swine, Miniature; Time Factors; Ultrasonography; Vascular Patency; Wound Healing | 2012 |
Single-center experience with extracorporeal life support in 103 nonpostcardiotomy patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Pressure; Biomarkers; Cardiovascular Agents; Catecholamines; Chi-Square Distribution; Child; Child, Preschool; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Germany; Heart Arrest; Hospital Mortality; Humans; Hydrogen-Ion Concentration; Lactic Acid; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2013 |
A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
Topics: Animals; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Cardiovascular Agents; Cell Line; Chemistry, Pharmaceutical; Cytokines; Delayed-Action Preparations; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Echocardiography, Doppler; Fibroblasts; Heart Failure; Humans; Injections, Intramuscular; Lactic Acid; Microscopy, Electron; Mitochondria, Heart; Myocardium; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Recovery of Function; RNA, Messenger; Stroke Volume; Time Factors; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Microencapsulation of mildronate in biodegradable and non-biodegradable polymers.
Topics: Animals; Capsules; Cardiovascular Agents; Kinetics; Lactic Acid; Male; Methylhydrazines; Polyesters; Polymers; Polystyrenes; Rabbits | 2014 |
Solely abluminal drug release from coronary stents could possibly improve reendothelialization.
Topics: Animals; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Lactic Acid; Models, Animal; Neointima; Percutaneous Coronary Intervention; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Design; Re-Epithelialization; Swine; Time Factors | 2016 |
Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiovascular Agents; Follow-Up Studies; Hospital Mortality; Humans; Lactic Acid; Operative Time; Prognosis; Renal Replacement Therapy; Retrospective Studies; Risk Factors | 2013 |
FEA study on the stress distributions in the polymer coatings of cardiovascular drug-eluting stent medical devices.
Topics: Arteries; Cardiovascular Agents; Chromium; Drug-Eluting Stents; Finite Element Analysis; Lactic Acid; Materials Testing; Models, Theoretical; Plaque, Atherosclerotic; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Steel; Stress, Mechanical | 2014 |
First reported use of drug-eluting bioabsorbable vascular scaffold in congenital heart disease.
Topics: Absorbable Implants; Angioplasty, Balloon; Cardiovascular Agents; Child; Coated Materials, Biocompatible; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Lactic Acid; Male; Polyesters; Polymers; Prosthesis Design; Pulmonary Artery; Recurrence; Treatment Outcome; Vascular Patency | 2016 |
Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Vessels; Crystallization; Drug-Eluting Stents; Everolimus; Lactic Acid; Linear Models; Models, Animal; Observer Variation; Polyesters; Polymers; Predictive Value of Tests; Prosthesis Design; Reproducibility of Results; Swine; Time Factors; Ultrasonography, Interventional | 2015 |
Drag-reducing polymers increase exercise tolerance in an ischemic hind-limb rat model.
Topics: Animals; Biomarkers; Cardiovascular Agents; Creatine Kinase; Disease Models, Animal; Exercise Tolerance; Hindlimb; Injections, Intravenous; Ischemia; L-Lactate Dehydrogenase; Lactic Acid; Male; Microcirculation; Muscle, Skeletal; Nitric Oxide; Polyethylene Glycols; Rats, Wistar; Regional Blood Flow; Running; Time Factors | 2016 |
Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts.
Topics: Animals; Biological Availability; Biotinylation; Cardiovascular Agents; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Stability; Female; Humans; Lactic Acid; Macrophages; Myocardial Infarction; Myocardium; Neuregulin-1; Particle Size; Phagocytosis; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Receptor, ErbB-4; Recombinant Proteins | 2015 |
Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug.
Topics: Barium Compounds; Cardiovascular Agents; Cell Adhesion; Cells, Cultured; Coronary Restenosis; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Muscle, Smooth, Vascular; Nanoparticles; Nanostructures; Polyesters; Polymers; Pyridines; Pyrimidinones; Titanium; Ultrasonics | 2016 |
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Topics: Administration, Intravenous; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Brachiocephalic Trunk; Cardiovascular Agents; Cathepsins; Cell Differentiation; Cells, Cultured; Chemistry, Pharmaceutical; Cytokines; Diet, High-Fat; Disease Models, Animal; Disease Progression; Drug Carriers; Inflammation Mediators; Lactic Acid; Macrophages, Peritoneal; Male; Matrix Metalloproteinases; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Nanoparticles; Phenotype; Pioglitazone; Plaque, Atherosclerotic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rupture, Spontaneous; Thiazolidinediones | 2016 |
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Topics: Angioplasty, Balloon; Animals; Aorta; Cardiovascular Agents; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Cytoskeleton; Disease Models, Animal; Docosahexaenoic Acids; Drug Carriers; Drug Compounding; Hyperplasia; Inflammation Mediators; Ki-67 Antigen; Lactic Acid; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxidative Stress; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Time Factors; Transcription Factor RelA | 2017 |
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Lactic Acid; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2017 |